Carbapenem-Resistant Enterobacteriaceae Infections in Children.

TitleCarbapenem-Resistant Enterobacteriaceae Infections in Children.
Publication TypeJournal Article
Year of Publication2016
AuthorsChiotos K, Han JH, Tamma PD
JournalCurr Infect Dis Rep
Date Published2016 Jan

Carbapenem-resistant Enterobacteriaceae (CRE) are an emerging global public health threat. Infections due to CRE are associated with significant morbidity and mortality. Few therapeutic options are available for treatment of these infections, and optimal antibiotic treatment regimens are unclear. Along with the rapidly increasing prevalence of CRE in the USA and worldwide, several studies have described the epidemiology of CRE in the adult population. While CRE are now also reported sporadically in children, there is a significant lack of data on the epidemiology, risk factors, treatment, and outcomes in this population. This article provides a comprehensive review of what is known to date about CRE, including clinical and molecular epidemiology, microbiologic diagnosis, antibiotic treatment options, and outcomes. In particular, this review will focus on the available data on CRE in the pediatric population.

Alternate JournalCurr Infect Dis Rep
PubMed ID26711126